These guidelines explain the policies and procedures of the
National Drug Abuse Treatment Clinical Trials Network (CTN).
Some of these guidelines reflect Department of Health and
Human Service requirements for federally funded clinical research
while others are the result of a consensus among NIDA staff,
the CTN Steering Committee, and qualified extramural clinical
investigators. These guidelines have been updated to reflect
current practices. Although further evolution of these guidelines
is inevitable, it is hoped that the codification of NIDA CTN
policies and procedures will continue to encourage a research
philosophy and discipline that will produce consistently excellent
clinical trials that will ultimately improve the treatment
of drug addiction in the United States.
Our policy and procedure information materials are provided
in PDF format. In order to view the file, you will need Adobe
Acrobat Reader.
If you have the Acrobat reader plug-in for Netscape or Internet
Explorer click on the document links below and you will be
able to view and/or print out the pages. If you do not have
the plug-in, you will need to download the document to your
hard drive.
The Reader can be downloaded for free from www.adobe.com.
